- Home
- CATO vs XTNT Comparison
CATO vs XTNT Comparison
Compare CATO & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- XTNT
- Stock Information
- Founded
- CATO 1946
- XTNT N/A
- Country
- CATO United States
- XTNT United States
- Employees
- CATO N/A
- XTNT N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CATO Consumer Discretionary
- XTNT Health Care
- Exchange
- CATO Nasdaq
- XTNT Nasdaq
- Market Cap
- CATO 77.6M
- XTNT 69.3M
- IPO Year
- CATO N/A
- XTNT N/A
- Fundamental
- Price
- CATO $3.38
- XTNT $0.62
- Analyst Decision
- CATO
- XTNT Strong Buy
- Analyst Count
- CATO 0
- XTNT 1
- Target Price
- CATO N/A
- XTNT $3.00
- AVG Volume (30 Days)
- CATO 70.3K
- XTNT 60.8K
- Earning Date
- CATO 03-20-2025
- XTNT 11-12-2024
- Dividend Yield
- CATO 15.22%
- XTNT N/A
- EPS Growth
- CATO N/A
- XTNT N/A
- EPS
- CATO N/A
- XTNT N/A
- Revenue
- CATO $666,779,000.00
- XTNT $113,862,000.00
- Revenue This Year
- CATO N/A
- XTNT $31.27
- Revenue Next Year
- CATO N/A
- XTNT $13.07
- P/E Ratio
- CATO N/A
- XTNT N/A
- Revenue Growth
- CATO N/A
- XTNT 45.11
- 52 Week Low
- CATO $3.02
- XTNT $0.33
- 52 Week High
- CATO $7.05
- XTNT $1.30
- Technical
- Relative Strength Index (RSI)
- CATO 38.50
- XTNT 62.42
- Support Level
- CATO $3.46
- XTNT $0.50
- Resistance Level
- CATO $3.93
- XTNT $0.65
- Average True Range (ATR)
- CATO 0.18
- XTNT 0.07
- MACD
- CATO -0.01
- XTNT 0.00
- Stochastic Oscillator
- CATO 28.00
- XTNT 72.22
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.